Adult Acute Lymphocytic Leukemia
|
disease |
|
Neoplastic Process
|
860
|
154
|
0.040 |
None |
1.000 |
4 |
|
2013 |
2017 |
Waist-Hip Ratio
|
phenotype |
|
Organism Attribute
|
565
|
1138
|
0.100 |
None |
1.000 |
3 |
2
|
2018 |
2019 |
Progressive Neoplastic Disease
|
phenotype |
|
Neoplastic Process
|
384
|
40
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2019 |
HER2 gene amplification
|
disease |
|
Disease or Syndrome
|
170
|
14
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2020 |
B-CELL MALIGNANCY, LOW-GRADE
|
disease |
|
Neoplastic Process
|
350
|
19
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2017 |
Progressive cGVHD
|
disease |
|
Disease or Syndrome
|
384
|
40
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2019 |
Malignant neoplasm of colon and/or rectum
|
disease |
|
Neoplastic Process
|
3669
|
502
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Monocyte count procedure
|
phenotype |
|
Laboratory Procedure
|
139
|
296
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
1 |
2
|
2016 |
2016 |
Blood basophil count (lab test)
|
phenotype |
|
Laboratory Procedure
|
272
|
452
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Reticulocyte count (procedure)
|
phenotype |
|
Laboratory Procedure
|
234
|
474
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Monocyte count result
|
phenotype |
|
Laboratory or Test Result
|
139
|
296
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Estrogen receptor positive tumor
|
disease |
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Serous Tubal Intraepithelial Carcinoma
|
disease |
|
Neoplastic Process
|
33
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Blushing
|
phenotype |
Behavior and Behavior Mechanisms
|
Sign or Symptom
|
8
|
1
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Abnormal behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
910
|
121
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Prune Belly Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
83
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adenomatous Polyposis Coli
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
609
|
237
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Turner Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
162
|
21
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Gonadal Dysgenesis, 45,X
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
23
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Autoimmune Lymphoproliferative Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
65
|
22
|
0.010 |
None |
1.000 |
1 |
1
|
2008 |
2008 |
Tuberous Sclerosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
289
|
55
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
TUBEROUS SCLEROSIS 2 (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nervous System Diseases
|
Disease or Syndrome
|
43
|
255
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Charcot-Marie-Tooth Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
208
|
136
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |